Cite
Estimating the relative frequency of leukodystrophies and recommendations for carrier screening in the era of next-generation sequencing.
MLA
Schmidt, Johanna L., et al. “Estimating the Relative Frequency of Leukodystrophies and Recommendations for Carrier Screening in the Era of Next-Generation Sequencing.” American Journal of Medical Genetics. Part A, vol. 182, no. 8, Aug. 2020, pp. 1906–12. EBSCOhost, https://doi.org/10.1002/ajmg.a.61641.
APA
Schmidt, J. L., Pizzino, A., Nicholl, J., Foley, A., Wang, Y., Rosenfeld, J. A., Mighion, L., Bean, L., da Silva, C., Cho, M. T., Truty, R., Garcia, J., Speare, V., Blanco, K., Powis, Z., Hobson, G. M., Kirwin, S., Krock, B., Lee, H., … Vanderver, A. (2020). Estimating the relative frequency of leukodystrophies and recommendations for carrier screening in the era of next-generation sequencing. American Journal of Medical Genetics. Part A, 182(8), 1906–1912. https://doi.org/10.1002/ajmg.a.61641
Chicago
Schmidt, Johanna L, Amy Pizzino, Jessica Nicholl, Allison Foley, Yue Wang, Jill A Rosenfeld, Lindsey Mighion, et al. 2020. “Estimating the Relative Frequency of Leukodystrophies and Recommendations for Carrier Screening in the Era of Next-Generation Sequencing.” American Journal of Medical Genetics. Part A 182 (8): 1906–12. doi:10.1002/ajmg.a.61641.